This report analyzes the worldwide markets for Imaging Agents in US$ Million by the following Product Segments: Contrast Media (X-Ray, MRI, & Ultrasound), and Diagnostic Radiopharmaceuticals. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for each region for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 55 companies including many key and niche players such as AMAG Pharmaceuticals Inc., Bayer Schering Pharma AG, Bracco Group, Covidien, Daiichi Sankyo Company Limited, Eisai Co., Ltd, EUSA Pharma, Inc., GE Healthcare, Guerbet Group, and Lantheus Medical Imaging. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
Table of Contents
Table of Contents
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
A. Contrast Media
X-Ray Contrast Media
Magnetic Resonance Imaging (MRI) Contrast Media
Ultrasound Contrast Media
B. Diagnostic Radiopharmaceuticals
II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW
Industry Outlook
Medical Imaging Industry Under the Impact of Economic Downturn
Radioactive Isotopes Utilized in PET & SPECT Imaging Procedures
Radiopharmaceuticals-An Exotic Tool
Nanomaterials Taking the Center Stage
Gadolinium Coated Nanoparticles- A Promising Imaging Agent
A Peek Into Pricing Dynamics
A Synoptic Overview
Pros & Cons
Positive Factors Driving Prices
Negative Factors Bearing Down on Prices
Reimbursements
"Under the Umbrella"
Europe
United States
2. MARKET TRENDS & ISSUES
Falling Prices Turn On the Heat
X-Ray Contrast Media: Declining Sector
MRI Contrast Media: Playing at Center Court
Impact Wielded by Ballooning MRI Practices
Ultrasound Contrast Media: A Rising Star in the Quadrant
Fledging Market Battles Teething Challenges
PET: A Prime Growth Driver for Radiopharmaceuticals
Nuclear Medicine: A Potential Growth Avenue for Radiopharmaceuticals
Select Cardiology and Oncology Radiopharmaceuticals
3. COMPETITION
Market Structure
Big Guns in the Emerging MRI Market
Bayer Schering Pharma AG: A Pioneering Developer of MRI Contrast Agents
Competitive Scenario
Table 1: Worldwide Imaging Agents Market (2009): Percentage Breakdown of Value Sales for Leading Players- GE Healthcare, Bracco, Covidien, Bayer Schering Pharma, and Others (includes corresponding Graph/Chart)
Table 2: X-ray Medical Contrast Media Market Worldwide (2009): Percentage Breakdown of Sales for GE Healthcare, Bracco, Covidien, Bayer Schering Pharma and Others (includes corresponding Graph/Chart)
Table 3: MRI Contrast Media Market Worldwide (2009): Percentage Breakdown of Sales for Bayer Schering Pharma, GE Healthcare, Bracco, Covidien and Others (includes corresponding Graph/Chart)
Table 4: Radiopharmaceutical Contrast Media Market Worldwide: Percentage Share of Leading Players for 2007 - GE Healthcare, Bristol-Myers Squibb, Mallinckrodt/ Covidien, MDS Nordion and Others (Revenue Share) (includes corresponding Graph/Chart)
4. TECHNOLOGY BREAKTHROUGHS
Molecular Imaging Agents: The Outer Limits
On Cards: Hyperpolarized Gases as Contrast Agents
Imaging Agents Make a Welcome Impact in the Field of Alzheimer's Disease
Technetium-99m: A Breakthrough Contrast Agent for CNS Imaging
A New Imaging Agent for Radiopharmaceutical Scans
Multi-Modal Image Registration: Combating Contrast Medium Inconsistencies
Saline Flushes To Help Ensure Accurate Delivery of Contrast Agents
5. PRODUCT OVERVIEW
Contrast Agents
Contrast Media: How Do They Function?
Where Are They Used...?
Evolution of Contrast Media: A Profile
Bismuth Nitrate: Beginning of Contrast Agents
Imaging Agents: Significant Developments in the Last Fifty Years
Schering Develops First Intravenous Contrast Agent
MRI: Creating a New Era for Contrast Agents
A Peek into the Finer Points of Differences Among Contrast Media
Viscosity
Osmolality
Chemotoxicity
Second Generation Non-Ionic Contrast Agents: An Introduction
Choice of the Contrast Medium: A Weighty Decision
Factors affecting choice of Imaging Agents
Taxonomy
Types of Contrast Media
X-Ray Contrast Medium
First Generation High Osmolar Contrast Media
Second Generation Low Osmolar Contrast Media or LOCM
Table 5: Comparative Analysis of Structure of Non-ionic and ionic X-ray Contrast Media
MRI Contrast Medium
Role of Contrast Enhancement in MR Angiography (MRA)
MRI Contrast Agents for the Liver
Paramagnetic extracellular contrast agents
Hepatobiliary Gadolinium Chelates
Superparamagnetic Iron Oxide Particles
Ultrasound Contrast Medium
Ultrasonographic Contrast Media: What Are They?
Ultrasound Contrast Enhancement in Cardiology
Functionalities of Vascular Ultrasound Contrast Agents
Diagnostic Radiopharmaceuticals
Key Radioactive Isotopes used as Diagnostic Radiopharmaceuticals
A Delineate of Diagnostic Radiopharmaceuticals
Diagnostic Radiopharmaceuticals: A Technical Run-Through
Applications
6. A SEGMENTAL REVIEW
Contrast Media
Popular Brands of Contrast Agents
X-ray Contrast Media
Market Scenario
MRI Contrast Media
Market Scenario
Ultrasound Contrast Media
Market Overview
Competitive Scenario
Diagnostic Radiopharmaceuticals
Market Overview
Immunoconjugates
Market Overview
7. TECHNOLOGY DYNAMICS
Proprietary Technologies Making Significant In-Roads
Fujifilm Acquires Stake in Daiichi Radioisotope Laboratories
Bracco Diagnostics Inks Agreement with Amerinet
Vasovist receives Green Signal in Australia
AION Diagnostics Develops BioSilicon TM
Sonazoid Receives Import Approval
11. PRODUCT INTRODUCTIONS/INNOVATIONS - A HISTORIC PERSPECTIVE BUILDER
Insight Agents to Launch Generic Contrast Media Solutions In Europe
Researchers Develop First Biocompatible MRI Contrast Agent
Signalomics and Invitrogen Collaborate to Develop Nanocrystal Reagents
Schering AG Collaborates with Stanford University to Develop Molecular Imaging Agent
Schering and Avid to Develop Diagnostic Imaging Agents
US National Institutes of Health Develops two PET Imaging Agents
12. FOCUS ON SELECT PLAYERS
AMAG Pharmaceuticals, Inc. (USA)
Bayer Schering Pharma AG (Germany)
Bracco Group (Italy)
Covidien (USA)
Daiichi Sankyo Company Limited (Japan)
Eisai Co Ltd. (Japan)
EUSA Pharma, Inc. (UK)
GE Healthcare (UK)
Guerbet Group (France)
Lantheus Medical Imaging (USA)
13. GLOBAL MARKET PERSPECTIVE
Table 6: World Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 7: World Historic Review for Imaging Agents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 8: World 15-Year Perspective for Imaging Agents by Geographic Region- Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin America Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 9: World Recent Past, Current & Future Analysis for Contrast Media by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 10: World Historic Review for Contrast Media by Geographic Region - US, Canada, Japan, Europe, Asia- Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 11: World 15-Year Perspective for Contrast Media by Geographic Region- Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin America Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 12: World Recent Past, Current & Future Analysis for Contrast Media by Product Segments - X-Ray, MRI and Ultrasound Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 13: World Historic Review for Contrast Media by Product Segments - X-Ray, MRI and Ultrasound Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 14: World 15-Year Perspective for Contrast Media by Product Segments - Percentage Breakdown of Dollar Sales for X-Ray, MRI and Ultrasound Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 15: World Recent Past, Current & Future Analysis for X-Ray Contrast Media by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 16: World Historic Review for X-ray Contrast Media by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 17: World 15-Year Perspective for X-Ray Contrast Media by Geographic Region- Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin America Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 18: World Recent Past, Current & Future Analysis for MRI Contrast Media by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 19: World Historic Review for MRI Contrast Media by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 20: World 15-Year Perspective for MRI Contrast Media by Geographic Region- Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin America Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 21: World Recent Past, Current & Future Analysis for Ultrasound Contrast Media by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 22: World Historic Review for Ultrasound Contrast Media by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 23: World 15-Year Perspective for Ultrasound Contrast Media by Geographic Region- Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin America Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 24: World Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 25: World Historic Review for Diagnostic Radiopharmaceuticals by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 26: World 15-Year Perspective for Diagnostic Radiopharmaceuticals by Geographic Region- Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin America Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
III. MARKET
1. THE UNITED STATES
A. Market Analysis
Outlook
Imaging Centers Feel the Heat During Recession
Growth Stimulants
Dynamics of Pricing
Diagnostic Radiopharmaceuticals
Market Scenario
Availability of Isotopes: A Tough Challenge
Radiopharmaceuticals to Drive Growth
Competitive Analysis - Imaging Market
Reimbursement Issues
Medicare
Magnetic Resonance Imaging
Regulatory Environment
Provisions Regarding Off-Label Usage of Contrast Media
Contrast Media
X-ray Contrast Media
MRI Contrast Media
Market Scenario
Managed Care Vs MRI Technology Diffusion
Ultrasound Contrast Media
B. Market Analytics
Table 27: US Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 28: US Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 29: US 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
2. CANADA
A. Market Analysis
Outlook
Diagnostic Equipment Market
LOCM Products Approved in Canada
B. Market Analytics
Table 30: Canadian Recent Past, Current & Future Analysis for Imaging Agents by Product Segment- Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 31: Canadian Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 32: Canadian 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
3. JAPAN
A. Market Analysis
Outlook
Reimbursement Issues
B. Market Analytics
Table 33: Japanese Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 34: Japanese Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 35: Japanese 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
4. EUROPE
A. Market Analysis
Outlook
Trends
Reimbursement
Outsourcing of Imaging Diagnostics
Distribution Structure
Direct Sales
License Agreements
Distribution Agreements
A Price Sensitive Market
Macro Environment
Germany
France
Spain & Italy
Scandinavia
B. Market Analytics
Table 36: European Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - France, Germany, UK, Italy, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 37: European Historic Review for Imaging Agents by Geographic Region - France, Germany, UK, Italy, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 38: European 15-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, UK, Italy, Spain, Russia and Rest of Europe Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 39: European Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 40: European Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 41: European 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
4a. FRANCE
A. Market Analysis
Growth Stimulants
B. Market Analytics
Table 42: French Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 43: French Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 44: French 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) & Diagnostic Radiopharmaceuticals Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
4b. GERMANY
Market Analytics
Table 45: German Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 46: German Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 47: German 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
4c. ITALY
Market Analytics
Table 48: Italian Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 49: Italian Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 50: Italian 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
4d. THE UNITED KINGDOM
Market Analytics
Table 51: UK Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 52: UK Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 53: UK 15-Year Perspective for Imaging Agents by Product Segment Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
4e. SPAIN
Market Analytics
Table 54: Spanish Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 55: Spanish Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 56: Spanish 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
4f. RUSSIA
Market Analytics
Table 57: Russian Recent Past, Current & Future Analysis for Imaging Agents by Product Segment -Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 58: Russian Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 59: Russian 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
4g. REST OF EUROPE
Market Analytics
Table 60: Rest of Europe Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 61: Rest of Europe Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 62: Rest of Europe 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
5. ASIA-PACIFIC
A. Market Analysis
MRI Market in Asia
ANSTO: Leading the Radiopharmaceuticals Market
India - A High Potential Market
B. Market Analytics
Table 63: Asia-Pacific Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 64: Asia-Pacific Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 65: Asia-Pacific 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
6. THE MIDDLE EAST
Market Analytics
Table 66: Middle East Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 67: Middle East Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 68: Middle East 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
7. LATIN AMERICA
A. Market Analysis
Private Sector Boosts Healthcare Segment
B. Market Analytics
Table 69: Latin American Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 70: Latin American Historic Review for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 71: Latin American 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
IV. COMPETITIVE LANDSCAPE
Imaging Agents published by Global Industry Analysts, Inc. in February 1, 2012. This report consists of Pages: 450 and the price starts from US $ 4500.
The contents of this page may be different from the latest version. Please contact us for details.
